| 000 | 01492 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516163610.0 | ||
| 264 | 0 | _c20160408 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1857-9345 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTrojacanec, J | |
| 245 | 0 | 0 |
_aPerindopril treatment in streptozotocin induced diabetic nephropaty. _h[electronic resource] |
| 260 |
_bPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) _c2013 |
||
| 300 |
_a99-108 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlbuminuria _xchemically induced |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBlood Urea Nitrogen |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerulonephritis _xblood |
| 650 | 0 | 4 | _aHypertrophy |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPerindopril _xpharmacology |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStreptozocin |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aZafirov, D | |
| 700 | 1 | _aLabacevski, N | |
| 700 | 1 | _aJakjovski, K | |
| 700 | 1 | _aZdravkovski, P | |
| 700 | 1 | _aTrojacanec, P | |
| 700 | 1 | _aPetrusevska, G | |
| 773 | 0 |
_tPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) _gvol. 34 _gno. 1 _gp. 99-108 |
|
| 999 |
_c22988400 _d22988400 |
||